VR Logo

Unrated

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Direct Plan download report


1 Lakh

Investment declined to
₹ 0.92 Lakh

₹ 10000

Monthly SIP Declined to
₹ 1.12 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-G -12.55 -0.28 0.34 -2.85 -8.17 -12.55 -8.24 -- -- -- --
S&P BSE Healthcare TRI* -16.82 0.62 0.34 -2.06 -10.68 -16.82 -15.08 -- -- -- --
Equity: Sectoral-Pharma* -15.18 0.70 0.57 -1.35 -9.36 -15.18 -11.74 -- -- -- --

As on 30-Jun-2022

* As on 01-Jul-2022

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Direct Plan  | Invest Online
Unrated
Oct-20 -8.24 -- -- 0.46% 157
Nippon India Pharma Fund - Direct Plan
Unrated
Jan-13 -13.45 23.60 16.40 1.04% 4,516
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund - Direct Plan  | Invest Now
Unrated
Jul-18 -11.23 24.31 -- 1.23% 2,316
Mirae Asset Healthcare Fund - Direct Plan  | Invest Online
Unrated
Jul-18 -9.01 28.10 -- 0.64% 1,692
SBI Healthcare Opportunities Fund - Direct Plan  | Invest Online
Unrated
Jan-13 -12.50 23.40 11.02 1.07% 1,638

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 4.83 17-Jun-2022 - 24-Jun-2022 -5.14 02-May-2022 - 10-May-2022
Month 12.43 19-Mar-2021 - 20-Apr-2021 -9.42 11-Apr-2022 - 11-May-2022
Quarter 17.66 18-Mar-2021 - 17-Jun-2021 -11.74 17-Mar-2022 - 17-Jun-2022
Year 26.57 02-Nov-2020 - 02-Nov-2021 -9.94 17-Jun-2021 - 17-Jun-2022

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-G -- -- -- -- -- --
S&P BSE Healthcare TRI* 20.37 22.36 0.75 1.50 -- --
Equity: Sectoral-Pharma* 23.61 20.44 0.99 2.00 0.89 5.06

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 30-Jun-2022

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 44
Top 10 Stocks (%) 51.65
Top 5 Stocks (%) 39.41
Top 3 Sectors (%) 99.98
Portfolio P/B Ratio 110.29
Portfolio P/E Ratio 968.33

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 1,58,289 55,629
Giant (%) 42.37 19.21
Large (%) 31.05 38.04
Mid (%) 25.98 35.58
Small (%) 0.60 7.07
Tiny (%) -- 0.73

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
down Sun Pharmaceutical Industries Healthcare 60.61 11.48 0.00 11.00
down Dr. Reddy's Lab Healthcare 33.43 9.96 0.00 7.75
down Cipla Healthcare 30.42 7.32 0.00 7.32
down Divi's Laboratories Healthcare 32.68 9.72 0.00 7.26
up Apollo Hospitals Healthcare 50.82 8.00 0.00 6.08
equal Johnson & Johnson Healthcare -- 5.02
equal Pfizer INC Healthcare -- 3.12
down Laurus Labs Healthcare 30.33 3.27 0.00 2.78
up Max Healthcare Institute Healthcare 57.69 2.76 0.00 2.76
equal AbbVie Inc Healthcare -- 2.68
equal Merck & Co Inc (US) Healthcare -- 2.39
down Aurobindo Pharma Healthcare 11.57 4.59 0.00 2.37
equal Thermo Fisher Scientific Inc Healthcare -- 2.36
equal Abbott Laboratories Healthcare -- 2.21
down Torrent Pharmaceuticals Healthcare 63.59 2.34 0.00 2.19
down Lupin Healthcare -- 4.30 0.00 2.14
down Biocon Healthcare 57.70 3.21 0.00 2.13
equal Novartis AG (ADS/ADR) Healthcare -- 2.08
down Ipca Laboratories Healthcare 26.20 2.65 0.00 1.93
equal Danaher Corporation Healthcare -- 1.82
equal Bristol-Myers Squibb Co Healthcare -- 1.74
down Fortis Healthcare Healthcare 32.06 1.92 0.00 1.64
equal Amgen Inc. (USA) Healthcare -- 1.51
equal Medtronic Healthcare -- 1.44
down Abbott India Healthcare 50.77 1.53 0.00 1.43

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-May-2022

Fund Manager

— Bhavesh Jain since 01-Oct-2021

Education: Mr. Jain is a MMS (Finance) from Mumbai University.

Experience: Prior to joining Edelweiss Mutual Fund he was previously associated with Edelweiss Securities Limited as SGX Nifty Arbitrage Trader.

Funds Managed:


0.94%

Change from previous, NAV as on 01-Jul-2022

Growth: ₹ 11.6183

IDCW: ₹ 11.6183


Investment Strategy

The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.

Investment Details

Min. Investment (₹) 5,000
Min. Addl Investment (₹) 500
Min. SIP Investment (₹) 500
Min. No of Cheques 12
Min. Withdrawal (₹) 500
Min. Balance (₹) --
Lock-in Period Not Applicable
Exit Load 0

Basic Details

Fund House: Edelweiss Mutual Fund
Launch Date: 26-Oct-2020
Return Since Launch: 8.75%
Benchmark: MSCI India Domestic & World HC 45 Index
Riskometer: Very High
Type: Open-ended
Assets: ₹ 157 Cr (As on 31-May-2022)
Expense: 0.46% (As on 31-May-2022)
Risk Grade: --
Return Grade: --
Turnover: --

Contact Information

AMC: Edelweiss Asset Management Ltd.

Address: Edelweiss House Off C.S.T. Road, Kalina Mumbai - 400098

Phone: +91 22 4093 3400

Fax: +91 22-40979878

Website: http://www.edelweissmf.com

Registrar & Transfer Agent: KFin Technologies Ltd.

Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016

Phone: 040-44857874

Email: [email protected]

Website: www.karvymfs.com

Upcoming Video

Investors' Hangout

All about nominations in mutual funds

DateFri, 08-Jul-2022
Time12:30 PM - 12:40 PM

attending You have reserved a spot